Effects of SQ 14.225, an Orally Active Inhibitor of Angiotensin-converting Enzyme, on Hypoxic Pulmonary Hypertension and Right Ventricular Hypertrophy in Rats

Overview

Journal Basic Res Cardiol

Specialty Cardiology & Vascular Diseases

Date 1981 May 1

PMID 6455994

Citations 6

Authors

D KENTERA

D Susic

A Cvetkovic

G Djordjevic

Affiliations

Soon will be listed here.

Abstract

Treatment with SQ 14.225, an inhibitor of the enzyme converting angiotensin I to angiotensin II and lowering of plasma renin activity by dietary salt overload, significantly decreased hypertrophy of the right ventricle in chronically hypoxic rats. The smaller degree of right ventricular hypertrophy registered in hypoxic rats with suppressed activity of the renin-angiotensin system was proportional to the decrease in hypoxic pulmonary hypertension noted in these animals. Lowering of pulmonary hypertension in chronically hypoxic rats by suppression of the renin-angiotensin system is consistent with the idea that angiotensin II may be involved in eliciting hypoxic pulmonary vasoconstriction. Inhibition of converting enzyme also lowered the systemic arterial pressure in hypoxic rats, but this finding could not be taken as evidence for the role of the renin-angiotensin system in homeostatic control of blood pressure in normal animals, since the plasma-renin activity in hypoxic rats is increased and the blood pressure higher than in rats kept under normoxic conditions.

Citing Articles

Effects of olmesartan, an AT1 receptor antagonist, on hypoxia-induced activation of ERK1/2 and pro-inflammatory signals in the mouse lung.

Tanabe Y, Morikawa Y, Kato T, Kanai S, Watakabe T, Nishijima A Naunyn Schmiedebergs Arch Pharmacol. 2006; 374(3):235-48.

PMID: 17089097 DOI: 10.1007/s00210-006-0110-1.

[Expression of angiotensin I converting enzyme in pulmonary hypertension].

Muller A, Maas M, Kozianka U, FRANKE F Pathologe. 2006; 27(2):133-9.

PMID: 16453109 DOI: 10.1007/s00292-006-0820-7.

Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung.

Zhao L, Sebkhi A, Owji A, Nunez D, Wilkins M Br J Pharmacol. 1996; 119(6):1217-22.

PMID: 8937726 PMC: 1915911. DOI: 10.1111/j.1476-5381.1996.tb16025.x.

Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

Morrell N, Atochina E, Morris K, Danilov S, Stenmark K J Clin Invest. 1995; 96(4):1823-33.

PMID: 7560074 PMC: 185819. DOI: 10.1172/JCI118228.

Contribution of polycythaemia to pulmonary hypertension in simulated high altitude in rats.

Barer G, Bee D, Wach R J Physiol. 1983; 336:27-38.

PMID: 6875909 PMC: 1198952. DOI: 10.1113/jphysiol.1983.sp014563.

References

Jaeger P, Ferguson R, Brunner H, Kirchertz E, Gavras H . Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats. Kidney Int. 1978; 13(4):289-96. DOI: 10.1038/ki.1978.42. View

Sen S, TARAZI R, Khairallah P, BUMPUS F . Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res. 1974; 35(5):775-81. DOI: 10.1161/01.res.35.5.775. View

Sen S, TARAZI R, BUMPUS F . Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res. 1977; 11(5):427-33. DOI: 10.1093/cvr/11.5.427. View

KENTERA D, Susic D, Cemerikic D . Plasma renin activity and hypertrophy of the right ventricle in hypoxic rats. Basic Res Cardiol. 1979; 74(4):445-50. DOI: 10.1007/BF01908396. View

Suggett A, Mohammed F, Barer G . Angiotensin, hypoxia, verapamil and pulmonary vessels. Clin Exp Pharmacol Physiol. 1980; 7(3):263-74. DOI: 10.1111/j.1440-1681.1980.tb00070.x. View

Fernandes M, Onesti G, Fiorentini R, Kim K, Swartz C . Effect of chronic administration of propranolol on the blood pressure and heart weight in experimental renal hypertension. Life Sci. 1976; 18(9):967-70. DOI: 10.1016/0024-3205(76)90416-1. View

Sancho J, Re R, Burton J, BARGER A, Haber E . The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Circulation. 1976; 53(3):400-5. DOI: 10.1161/01.cir.53.3.400. View

McCaa R, MCCAA C, Bengis R, GUYTON A . Role of aldosterone in experimental hypertension. J Endocrinol. 1979; 81(2):69P-78P. View

Weir E . Does normoxic pulmonary vasodilatation rather than hypoxic vasoconstriction account for the pulmonary pressor response to hypoxia?. Lancet. 1978; 1(8062):476-7. DOI: 10.1016/s0140-6736(78)90138-1. View

10.

KENTERA D, Susic D, Cenic D . Interaction of pulmonary and systemic hypertension. An experimental study. Cor Vasa. 1980; 22(4):294-9. View

11.

LANGE R, Simmons M, McDONALD T . Use of silicone rubber membrane enclosures for preparation of erythropoietin assay mice. Ann N Y Acad Sci. 1968; 149(1):34-9. DOI: 10.1111/j.1749-6632.1968.tb15132.x. View

12.

Couture R, Regoli D . Vascular reactivity to angiotensin and noradrenaline in rats maintained on a sodium free diet or made hypertensive with desoxycorticosterone acetate and salt (DOCA/salt). Clin Exp Hypertens (1978). 1980; 2(1):25-43. DOI: 10.3109/10641968009038550. View

13.

STREWLER G, Hinrichs K, Guiod L, Hollenberg N . Sodium intake and vascular smooth muscle responsiveness to norepinephrine and angiotensin in the rabbit. Circ Res. 1972; 31(5):758-66. DOI: 10.1161/01.res.31.5.758. View

14.

Su C, Bevan R, Duckles S, BEVAN J . Functional studies of the small pulmonary arteries. Microvasc Res. 1978; 15(1):37-44. DOI: 10.1016/0026-2862(78)90003-1. View

15.

HARRIS D, Heran C, Goldenberg H, High J, LAFFAN R, Rubin B . Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs. Eur J Pharmacol. 1978; 51(4):345-9. DOI: 10.1016/0014-2999(78)90426-0. View

16.

Samuels A, Miller Jr E, Fray J, Haber E, BARGER A . Renin--angiotensin antagonists and the regulation of blood pressure. Fed Proc. 1976; 35(13):2512-20. View

17.

KENTERA D, Susic D . Dynamics of regression of right ventricular hypertrophy in rats with hypoxic pulmonary hypertension. Respiration. 1980; 39(5):272-5. DOI: 10.1159/000194227. View